<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="T1" orientation="portrait" position="float">
 <label>TABLE 1</label>
 <caption>
  <p>Therapeutic options for COVID-19</p>
 </caption>
 <alternatives>
  <table frame="hsides" rules="groups">
   <colgroup span="1">
    <col span="1"/>
    <col span="1"/>
    <col span="1"/>
    <col span="1"/>
   </colgroup>
   <thead>
    <tr>
     <th rowspan="1" colspan="1">Therapeutic name</th>
     <th rowspan="1" colspan="1">Activity</th>
     <th rowspan="1" colspan="1">Effectiveness</th>
     <th rowspan="1" colspan="1">Reference</th>
    </tr>
   </thead>
   <tbody>
    <tr>
     <td rowspan="1" colspan="1">K22</td>
     <td rowspan="1" colspan="1">Targets membrane-bound replication complexes of virus in host cell to inhibit RNA synthesis</td>
     <td rowspan="1" colspan="1">Effective against SARS and MERS, thus could be effective against SARS-CoV-2.</td>
     <td rowspan="1" colspan="1">(
      <xref rid="B58" ref-type="bibr">58</xref>)
     </td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1">DRACO</td>
     <td rowspan="1" colspan="1">Targets viral dsRNA to induce apoptosis in cells containing virus</td>
     <td rowspan="1" colspan="1">Effective against a large group of viruses, therefore may have potential to target SARS-CoV-2.</td>
     <td rowspan="1" colspan="1">(
      <xref rid="B51" ref-type="bibr">51</xref>, 
      <xref rid="B59" ref-type="bibr">59</xref>)
     </td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1">Mycophenolic acid</td>
     <td rowspan="1" colspan="1">Targets nucleosides and/or nucleotides to inhibit synthesis of guanine monophosphate</td>
     <td rowspan="1" colspan="1">Effective against a wide range of viruses, however combinatorial therapy with interferon beta1b may be useful for SARS-CoV-2.</td>
     <td rowspan="1" colspan="1">(
      <xref rid="B56" ref-type="bibr">56</xref>)
     </td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1">Lopinavir</td>
     <td rowspan="1" colspan="1">Targets 3CLpro enzyme to inhibit its activity</td>
     <td rowspan="1" colspan="1">Effective against a wide range of viruses, including SARS-CoV and MERS-CoV, thus could be a suitable choice for treatment of SARS-CoV-2 infection.</td>
     <td rowspan="1" colspan="1">(
      <xref rid="B60" ref-type="bibr">60</xref>)
     </td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1">Remdesivir</td>
     <td rowspan="1" colspan="1">Terminates transcription of viral RNA transcription at premature level</td>
     <td rowspan="1" colspan="1">Effective against a broad spectrum of viruses including MERS-CoV and SARS-CoV. The efficacy is very promising when combined with IFNb, hence could be a suitable therapeutic strategy for SARS-CoV-2.</td>
     <td rowspan="1" colspan="1">(
      <xref rid="B35" ref-type="bibr">35</xref>)
     </td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1">Ribavirin</td>
     <td rowspan="1" colspan="1">Targets RdRp (RNA‑dependent RNA polymerase) enzyme to inhibit synthesis of viral RNA synthesis and capping of mRNA</td>
     <td rowspan="1" colspan="1">Effective against a wide range of viruses, including MERS-CoV and SARS-CoV, but the high doses required may have severe side effects. Could be reevaluated for SARS-CoV-2 and recommended if low doses are found effective.</td>
     <td rowspan="1" colspan="1">(
      <xref rid="B35" ref-type="bibr">35</xref>, 
      <xref rid="B60" ref-type="bibr">60</xref>)
     </td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1">Bcx4430</td>
     <td rowspan="1" colspan="1">Targets RdRp (RNA‑dependent RNA polymerase) enzyme to inhibit synthesis of viral RNA synthesis and capping of mRNA</td>
     <td rowspan="1" colspan="1">Broad spectrum and effective against SARS-CoV and MERS-CoV, thus may be effective against SARS-CoV-2, however, evaluation using animal models is required.</td>
     <td rowspan="1" colspan="1">(
      <xref rid="B61" ref-type="bibr">61</xref>)
     </td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1">Bananins</td>
     <td rowspan="1" colspan="1">Target helicase to inhibit unwinding and activity of ATPase</td>
     <td rowspan="1" colspan="1">Have effects against broad-spectrum viruses and can be evaluated for SARS-CoV-2.</td>
     <td rowspan="1" colspan="1">(
      <xref rid="B1" ref-type="bibr">1</xref>)
     </td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1">Aryl diketoacids (Adks)</td>
     <td rowspan="1" colspan="1">Target helicase to inhibit its unwinding</td>
     <td rowspan="1" colspan="1">Effective for a broad range viruses, including SARS/MERS-CoV, and may be a suitable choice for SARS-CoV-2.</td>
     <td rowspan="1" colspan="1">(
      <xref rid="B1" ref-type="bibr">1</xref>)
     </td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1">Griffithsin</td>
     <td rowspan="1" colspan="1">Targets oligosaccharides on S to block viral binding with host cell</td>
     <td rowspan="1" colspan="1">Has effects against SARS/MERS-CoV and other high pathogenic viruses, thus might be used against SARS-CoV-2.</td>
     <td rowspan="1" colspan="1">(
      <xref rid="B62" ref-type="bibr">62</xref>)
     </td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1">Hexamethylene amiloride</td>
     <td rowspan="1" colspan="1">Targets viral envelope to inhibit ion channel activity</td>
     <td rowspan="1" colspan="1">Has effects against different coronaviruses, thus one of the most suitable treatment options for SARS-CoV-2.</td>
     <td rowspan="1" colspan="1">(
      <xref rid="B63" ref-type="bibr">63</xref>)
     </td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1">Jl103</td>
     <td rowspan="1" colspan="1">Targets lipid membrane and causes modification of phospholipids</td>
     <td rowspan="1" colspan="1">Has effects against different viruses and may be promising as an anti-SARS-CoV-2 agent.</td>
     <td rowspan="1" colspan="1">(
      <xref rid="B1" ref-type="bibr">1</xref>, 
      <xref rid="B60" ref-type="bibr">60</xref>)
     </td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1">Recombinant interferons</td>
     <td rowspan="1" colspan="1">Induce the innate interferon responses against viral pathogens</td>
     <td rowspan="1" colspan="1">Induce immune responses through recombinant interferons, found effective against a wide range of viruses and can be the most suitable option for SARS-CoV-2.</td>
     <td rowspan="1" colspan="1">(
      <xref rid="B1" ref-type="bibr">1</xref>, 
      <xref rid="B60" ref-type="bibr">60</xref>)
     </td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1">Nitazoxanide</td>
     <td rowspan="1" colspan="1">Induces the innate interferon responses against viral pathogens</td>
     <td rowspan="1" colspan="1">Induces immune responses through recombinant interferons, has been found effective against a wide range of viruses and may be promising to use against SARS-CoV-2.</td>
     <td rowspan="1" colspan="1">(
      <xref rid="B64" ref-type="bibr">64</xref>)
     </td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1">Cyclosporine, alisporivir</td>
     <td rowspan="1" colspan="1">Inhibit cyclophilin to affect calcineurin–NFAT pathway</td>
     <td rowspan="1" colspan="1">Inhibit broad-spectrum viruses, specifically coronaviruses, and thus could be suitable option to treat SARS-CoV-2.</td>
     <td rowspan="1" colspan="1">(
      <xref rid="B1" ref-type="bibr">1</xref>)
     </td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1">Rapamycin</td>
     <td rowspan="1" colspan="1">Inhibits kinase signaling associated pathways to block viral entry</td>
     <td rowspan="1" colspan="1">Effective against SARS/MERS-CoV and might possibly be effective against SARS-CoV-2.</td>
     <td rowspan="1" colspan="1">(
      <xref rid="B1" ref-type="bibr">1</xref>, 
      <xref rid="B65" ref-type="bibr">65</xref>)
     </td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1">Imatinib</td>
     <td rowspan="1" colspan="1">Inhibits kinase signaling associated pathways to block viral entry</td>
     <td rowspan="1" colspan="1">Effective against SARS/MERS-CoV and might possibly be effective against SARS-CoV-2.</td>
     <td rowspan="1" colspan="1">(
      <xref rid="B1" ref-type="bibr">1</xref>)
     </td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1">Dasatinib</td>
     <td rowspan="1" colspan="1">Inhibits kinase signaling associated pathways to block viral entry</td>
     <td rowspan="1" colspan="1">Effective against SARS/MERS-CoV and might possibly be effective against SARS-CoV-2.</td>
     <td rowspan="1" colspan="1">(
      <xref rid="B1" ref-type="bibr">1</xref>)
     </td>
    </tr>
   </tbody>
  </table>
  <graphic xlink:href="JCM.00187-20-t0001" xmlns:xlink="http://www.w3.org/1999/xlink"/>
 </alternatives>
</table-wrap>
